The Alzheimer’s Association celebrated on July 6, 2023 to the FDA’s action of approving Leqembi for treatment of early Alzheimer’s for people who showed elevation of amyloid beta. Dr. Joanne Pike, President Of The Alzheimer’s Association, said,” Even though this is not is cure it will give people in the early stages to maintain their…
Dementia, a debilitating condition affecting millions worldwide, has long been considered irreversible. However, Dr. John den Boer, a renowned neurologist, has introduced a groundbreaking non-medicated treatment approach that challenges this belief. By focusing on holistic methods and lifestyle changes, his innovative approach offers hope to dementia patients. In this blog, we will explore the principles…